AbbVie Inc (NYSE:ABBV)
| 46.42 Real-Time Quote |  -0.34 / -0.73%Today’s Change | 32.51 Today|||52-Week Range 48.00 | +35.89% Year-to-Date |
Latest ABBV News | Press Releases
| CE Mark for Abbott's Xience Xpedition 48 - Analyst Blog May 22 / Zacks.com | JNJ's Simponi Label Expanded - Analyst Blog May 21 / Zacks.com |
| Positive Data on Roche Candidate - Analyst Blog May 22 / Zacks.com | Excerpt From My Daily Journal Entry May 20 / StockTwits |
| Generic Launches at Mylan Continue - Analyst Blog May 22 / Zacks.com | Court stops EU regulator releasing drug trial data Apr 30 / FT.com |
| US doctors paid $1bn by top drug companies May 22 / FT.com | Apple launches biggest US corporate bond Apr 30 / FT.com |
| AbbVie Extends Galapagos Deal - Analyst Blog May 22 / Zacks.com | US pharma: spot the difference Apr 29 / FT.com |
Today’s Trading
| Previous close | 46.76 |
| Today’s open | 46.12 |
| Day’s range | 46.02 - 46.77 |
| Volume | 785,148 |
| Average volume (3 months) | 6,651,449 |
| Market cap | $74.1B |
| Dividend yield | 3.43% |
Data as of 10:49am ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | +54.24% |
| Earnings growth (this year) | -6.87% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +5.37% |
| P/E ratio | 11.8 |
| Price/Sales | 2.93 |
| Price/Book | 21.92 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk A/S | -1.67 | -0.98% |
| BMYBristol-Myers Squibb... | -0.04 | -0.09% |
| AZNAstraZeneca PLC | -0.82 | -1.57% |
| LLYEli Lilly and Co | -0.15 | -0.27% |
Data as of 10:50am ET, 05/23/2013
Financials
| Next reporting date | August 28, 2013 |
| EPS forecast (this quarter) | $0.79 |
| Annual revenue (last year) | $18.4B |
| Annual profit (last year) | $5.3B |
| Net profit margin | 28.70% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Richard A. Gonzalez |
Senior Vice President- Operations Azita Saleki-Gerhardt, PhD |
Corporate headquarters North Chicago, Illinois |
Forecasts
